Myers Lab
PROJECTS PROTOCOLS PUBLICATIONS
Richard M. Myers, Ph.D. (read bio)
President, Director and Investigator
contact
Research areas:
- Molecular basis of human inherited diseases and traits, including Huntington disease, Parkinson disease, bipolar disease, cancer, atherosclerosis, resistance to infectious agents, and differential responses to environmental assaults
- Human population genetics
- Functional genomics, including genome-scale analysis of cis-acting sequences, DNA binding proteins and epigenetic action involved in human gene regulation
- Genomic basis of vertebrate diversity
Collaborative project between Myers lab and Epicentre featured in Genome Research
News Outlet:
Genome Research
Date published:
December 1, 2011
Download PDF:
A collaborative effort between Epicentre and the HudsonAlpha Institute for Biotechnology resulted in the development of two novel transposon-based methods for RNA-Seq library preparation. The technique, called Tn-RNA-Seq, can use double-stranded cDNA created from rRNA-depleted RNA to prepare an Illumina sequencing library using only two enzymatic reactions. The researchers generated high-quality RNA-Seq libraries from as little as 10 pg of mRNA (~1 ng of total RNA) with this approach.
To read the rest of the article, click here.
The Cancer Genome Atlas completes detailed ovarian cancer analysis
HudsonAlpha Institute contributes to largest cancer genome study from NIH consortium
Watch Video
HUNTSVILLE, Ala - Integrating 500 patient samples and multiple genomic technologies, The Cancer Genome Atlas Research Network has, according to a release by the National Institutes of Health, assembled the most comprehensive view of cancer genes for any cancer type to date. The analyses of data are reported in the June 30 issue of Nature.
A User's Guide to ENcyclopedia of DNA Elements
HudsonAlpha is part of international team releasing massive dataset
HUNTSVILLE, Ala. - The international team of the ENCODE, or Encyclopedia Of DNA Elements project, has created an overview of its ongoing large-scale efforts to interpret the human genome sequence.
HudsonAlpha to use Sequencing to Uncover Genes Responsible for Adverse Drug Response in Parkinson's
News Outlet:
GenomeWeb
Date published:
March 8, 2011
Download PDF:
By Monica Heger
GenomeWeb
In an example of how sequencing can be used to study not onlythe genetic underpinnings of disease but also the genetics of drug response, researchers at the HudsonAlpha Institute for Biotechnology have teamed up with clinicians at the University of Alabama, Birmingham, to perform transcriptome sequencing on 200 brain tissue samples, from patients and healthy individuals, as well as whole-exome sequencing on the genomes of 100 Parkinson's patients enrolled in a clinical trial for the drug levodopa.
A faster turnaround in testing
News Outlet:
Technology Alabama
Date published:
November 22, 2010
Download PDF:
Newly announced HudsonAlpha resident associate company Kailos Genetics and Dr. K-T Varley of Myers Lab are featured in a Fall 2010 Technology Alabama article. The full story is attached as a PDF.
Gene linked with human kidney aging
News Outlet:
PLoS Genetics
Date published:
October 15, 2009
Download PDF:
A gene has been associated with human kidney aging, according to researchers from Stanford University, the National Institute on Aging, the MedStar Research Institute, and the HudsonAlpha Institute for Biotechnology. In work published on October 16 in the open-access journal PLoS Genetics, the investigators, including HudsonAlpha Faculty Investigators Rick Myers and Devin Absher, claim that their approach can be applied to any phenotype of interest to help find other genetic associations.
Leading a large lab
News Outlet:
Genome Technology
Date published:
September 1, 2009
Download PDF:
It is probably a safe bet that genomics would be a slightly different place had Richard Myers pursued his original path. Myers — now president and director of the Hudson-Alpha Institute for Biotechnology in Huntsville, Ala. — began his academic career as a sociology major at the University of Alabama in the mid-1970s. But halfway through, he ended up in a chemistry class that captured his interest and caused him to drop the softer science cold. And it's a good thing, too, because Myers went on to play a major role in the Human Genome Project, among many other large-scale collaborations. From 1993 until 2008, Myers was a professor in the department of genetics at Stanford University School of Medicine, where he also directed the Stanford Human Genome Center. In fact, Myers and his genome center contributed roughly 11 percent of the human sequence — chromosomes 5, 16, and 19.
